Full Text View
Tabular View
No Study Results Posted
Related Studies
Dose-Ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
This study is currently recruiting participants.
Study NCT00504426.   Last updated on January 8, 2009.
Information provided by Otsuka Pharmaceutical Co., Ltd.
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain Due to Osteoporosis
Additional conditions recognized in this trial
Osteoporosis
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Interventions listed in this trial
OPC-249
Sponsors listed in this trial
Otsuka Pharmaceutical Co., Ltd.


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services